Skip to main content

Logo (Actavis) 153 Pill - orange oval, 14mm

Pill with imprint Logo (Actavis) 153 is Orange, Oval and has been identified as Buprenorphine Hydrochloride (Sublingual) 8 mg (base). It is supplied by Actavis Pharma, Inc.

Buprenorphine is used in the treatment of Chronic Pain; Opiate Dependence - Maintenance; Opiate Dependence - Induction; Opioid Use Disorder; Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Buprenorphine 8 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for Logo (Actavis) 153

Buprenorphine hydrochloride (sublingual) 8 mg (base) Logo (Actavis) 153
Buprenorphine hydrochloride (sublingual) 8 mg (base) Logo (Actavis) 153
Buprenorphine hydrochloride (sublingual) 8 mg (base) Logo (Actavis) 153
Buprenorphine hydrochloride (sublingual) 8 mg (base) Logo (Actavis) 153

Buprenorphine Hydrochloride (Sublingual)

Imprint
Logo (Actavis) 153
Strength
8 mg (base)
Color
Orange
Size
14.00 mm
Shape
Oval
Availability
Prescription only
Drug Class
Opioids (narcotic analgesics)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00228-3153
Inactive Ingredients
citric acid anhydrous, FD&C Yellow No. 6, lactose monohydrate, magnesium stearate, mannitol, corn starch, povidone k30, trisodium citrate dihydrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.